PATENT CLAIM ANALYSIS

Application Number: 15934974
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["530", "300000"]

Abstract:
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical compositions containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.

Claim (Index 1):
A conjugate comprising a ligand of PSMA (B), a linker (L), and a drug (D), wherein the ligand includes one or more of a carbon-sulfur double bond, a phosphorus-sulfur double bond, a phosphorus-sulfur single bond, a thioester, or a combination thereof, and where the linker is covalently bound to the drug and the linker is covalently bound to the ligand, and where the linker comprises a chain of at least seven atoms.

Metadata:
- Claim Count in Document: 58.0
- Percentile: 90.0
- Lexical Diversity: 1.6
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15018068', '14794482', '12673931', '15606913', '13826079']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.636835646296242
- 35 USC 102 Novelty (BERT): 0.4980875553297451
- Combined Prediction Score: 0.6229608371995923
- Mean Citation Score: 272.04776000000004
- Max Citation Score: 280.61835
- Similarity Product: 244.7251375820071

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test